IRME — IR-MED Balance Sheet
0.000.00%
- $2.35m
- $2.49m
Annual balance sheet for IR-MED, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1.87 | 2.81 | 3 | 0.767 | 0.129 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.218 | 0.067 | 0.055 | 0.051 | 0.054 |
| Prepaid Expenses | |||||
| Total Current Assets | 2.08 | 2.88 | 3.06 | 0.848 | 0.205 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.006 | 0.031 | 0.226 | 0.14 | 0.035 |
| Other Long Term Assets | |||||
| Total Assets | 2.09 | 2.94 | 3.29 | 0.999 | 0.251 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.523 | 0.395 | 0.662 | 0.473 | 0.545 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.689 | 0.572 | 0.702 | 0.634 | 0.545 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 1.4 | 2.37 | 2.59 | 0.365 | -0.294 |
| Total Liabilities & Shareholders' Equity | 2.09 | 2.94 | 3.29 | 0.999 | 0.251 |
| Total Common Shares Outstanding |